Skip to content
Conference

Predicting Alzheimer’s Disease Progression from Mild Cognitive Impairment via Automated Brain Age Modeling

Aug 2026 · International Conference on Circuit, Power and Computing Technologies · pp. 617-621 · 0 citations · 16 references

Abstract

The early detection of individuals with Mild Cognitive Impairment (MCI) who are at high risk of developing Alzheimer’s Disease (AD) is important for proper clinical intervention and disease management. Studies show that there is a strong link between brain age, which is estimated from brain scan data, and actual chronological age. This difference is called the Brain Age Gap (BAG), and it acts as a useful biological marker for identifying people at risk of brain degeneration. This study aims to create an automated dual-network framework that predicts MCI subjects’ likelihood of converting to AD based on their structural magnetic resonance imaging (MRI) brain scans. The two networks will consist of (i) a three-dimensional convolutional neural network (CNN) model that predicts an estimated brain age based on the inputted MRI scan of a subject, and (ii) a risk prediction network that predicts probability of MCI-to-AD conversion by incorporating estimated brain age, BAG, and deep feature representations. The framework will be trained in sequential order using a longitudinal neuroimaging dataset. Results from the experiment indicate higher classification performance can be attained with the proposed dual-network architecture over current state-of-the-art single-stage classification methods or models without brain age. Furthermore, these results strongly support the use of brain age-based predictive features for early prediction of AD risk. The proposed method offers a fully automated and clinically interpretable solution for supporting early diagnosis and personalized intervention planning in Alzheimer’s disease.

View source

Similar papers

Conference Aug 2026

Early Detection of Mild Cognitive Impairment from Structural MRI Using Deep Learning and Explainable AI

Alzheimer's disease is a progressive neurodegenerative disease that leads to memory loss, cognitive decline and brain atrophy. Mild Cognitive Impairment is the early transitional stage between normal ageing and Alzheimer's disease in which brain structural changes start to appear but daily life functioning is still pre...

J. Surya, C. Mai, Madhubala Myneni · 0 citations
Open access Aug 2026

Development and validation of an amyloid PET dementia of the Alzheimer's type (DAT) score

The proposed 3D CNN accurately distinguished DAT from cognitively normal controls using amyloid PET imaging and showed promising performance across the AD continuum, supporting the potential of deep learning for early AD detection and clinical decision support.

Mitchell Edema, K. Popuri, Hyunwoo Lee et al. · 0 citations
Review Open access Aug 2026

Early Diagnosis of Alzheimer’s Disease USING DEEP learning MRI Images: A Systematic Review

Alzheimer's disease AD, also known as dementia, is a disease resulting from an irreversible brain disorder that can develop gradually as the patient ages. Its distinguishing features include cognitive decline, memory loss, and psychological problems. Early diagnosis of this disease becomes difficult due to the complexi...

Ali Kareem Obaid, Y. Farjami · 0 citations
Open access Sep 2026

A Deep Learning-Powered Framework for the Early Prediction of Alzheimer's Disease through Advanced Magnetic Resonance Imaging and Analysis.

An advanced DL-powered framework for the early prediction of AD using MRI data demonstrates high accuracy, robustness, and interpretability, supporting its potential for reliable early AD diagnosis in clinical settings.

K. V. S. V. Trinadh Reddy, Gundeboyina Srinivasalu, T. V. Rao et al. · 0 citations
Open access Aug 2026

Improving Alzheimer’s Disease Detection Based Deep Learning and Magnetic Resonance Imaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease that severely affects cognitive functions, which results in a serious memory impairment accompanied by personality changes. An active examination, which is sensitive and effective on time, is a must. Cerebrospinal fluid (CSF), Magnetic Resonance Imaging (M...

Hakar Hassan, Naaman Omar Yaseen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.